Tag: IPO
FiercePharmaAsia—10 Chinese biotechs to know; RemeGen’s $515M IPO; Sinovac COVD vax...
In China's booming biotech industry, we picked 10 leaders everyone should know about, because they'll likely compete on the global stage one day. China's RemeGen,...
2020 may be the year from hell, but health tech IPO...
On top of the ongoing Covid-19 pandemic, 2020 has been punctuated by devastation: raging wildfires, record unemployment and growing inequality. But despite all of...
Accolade makes debut on Nasdaq with upsized IPO
Accolade employees virtually celebrated its public debut in a video streamed in Times Square. The employee benefits platform will be listed on Nasdaq as...
Accolade seeks up to $211M in IPO
Employee benefits software company Accolade will seek up to $211 million in its market debut, according to documents filed with the Securities and Exchange...
Legend aims for $100M IPO as partner J&J mulls outpatient use...
The Chinese company that originally created a CAR-T for multiple myeloma now under clinical development by Johnson & Johnson is planning to go public,...
